Results from our previous study revealed that GEP44 binds to GLP-1R, Y1-R, and Y2-R 16
Sodium Safflowerate, Sorbitol (D-Glucitol), Hibiscus Sabdariffa Flower Extract, Propylene Glycol, Ricinus Communis (Castor) Seed Oil, Sorbitan Oleate, Salicylic Acid, Hydrolyzed Soy Protein, Glycyrrhiza Glabra (Licorice) Root Extract, Foeniculum Vulgare Dulce (Fennel) Oil, Lavandula Angustifolia (Lavender) Flower Oil, Alpha-Arbutin, Azelaic Acid, Glutathione, Kojic Acid, Niacinamide
The postoperative-ileus trial was a proof-of-concept development study
GLP-1 agonists, like Semaglutide and Tirzepatide, were originally used to treat type 2 diabetes
(2014) Glutathione
Peptides like Ipamorelin are not FDA-approved for general consumer use and may only be dispensed through licensed medical providers. FDA, Peptide Regulation Guidance WADA and Drug Testing Ipamorelin is listed on the World Anti-Doping Agency (WADA) Prohibited List under Peptide Hormones, Growth Factors, and Related Substances